Approved indications: Rhopressa (netarsudil ophthalmic solution 0.02%) is FDA‑approved to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Off-label uses: Some eye specialists may add Rhopressa in other glaucoma situations (such as normal-tension glaucoma or when other drops are insufficient), but these uses rely mainly on smaller studies and clinical experience and are not formally FDA‑approved.

Efficacy expectations:

• Rhopressa generally begins lowering eye pressure within hours of instillation, with full effect typically seen over several days to a few weeks.
• In clinical trials, once-daily use lowered IOP by roughly a few mmHg from baseline, helping many patients reach target pressure when used alone or with other glaucoma drops.
• It is often used in combination with other agents (such as prostaglandin analogs or beta-blocker drops) when additional pressure lowering is needed; compared with some older drugs it may cause more eye redness but has minimal systemic effects.

Role compared with similar drugs: Rhopressa offers a different mechanism (Rho kinase inhibition and increased trabecular outflow) and is commonly chosen as an add-on when first-line medicines like prostaglandin analogs or beta-blocker drops do not sufficiently control eye pressure.

Typical dosing: The usual adult dose is one drop in the affected eye or eyes once daily in the evening; using it more than once daily is not recommended because it does not improve effectiveness and may increase side effects.

Age considerations: Rhopressa is intended for adults; it is not approved for use in children or adolescents under 18 years because safety and effectiveness have not been established.

How to use the eye drops:

• Wash your hands, remove soft contact lenses, and gently shake the bottle if instructed.
• Tilt your head back, pull the lower eyelid down to form a small pocket, and instill one drop without letting the bottle tip touch your eye, eyelid, fingers, or any surface.
• Close your eye gently and, if possible, press a finger lightly at the corner of the eye near the nose for 1–2 minutes to reduce drainage into the nose and throat.
• If you use other eye drops, wait at least 5 minutes between Rhopressa and the other drops.
• Wait at least 15 minutes before reinserting contact lenses.

Special instructions: Use the drops at about the same time each evening, do not suddenly stop them without medical advice, and do not share your bottle with anyone else.

Missed dose: If you miss a dose, skip the missed dose and use your next dose at the usual evening time; do not use extra drops to make up for a missed dose.

Overdose: Using more drops than prescribed may increase eye irritation without improving pressure control; if a large amount is accidentally put into the eye, you may gently rinse with sterile saline or clean water and contact your eye doctor, and if the medicine is swallowed or overdose is suspected, seek medical advice or contact a poison control center (for example, 1‑800‑222‑1222 in the U.S.).

Common side effects:

• Very common: eye redness (conjunctival hyperemia), which may occur in over half of users, often appearing soon after starting the drops and usually mild to moderate.
• Common: a red spot on the white of the eye (conjunctival hemorrhage), corneal verticillata (harmless deposits on the cornea), mild eye pain or burning on instillation, blurred vision, tearing, or eyelid redness.
• Corneal verticillata typically develop after several weeks of use and usually do not affect vision and tend to resolve after stopping the medication.

Serious or rare adverse effects requiring immediate medical attention:

• Severe or persistent eye pain, marked redness, or sudden worsening of vision.
• Signs of corneal problems such as halos around lights, extreme sensitivity to light, or a sudden change in corneal clarity.
• Allergic reactions, including swelling of the face or eyelids, rash, or trouble breathing.

Warnings and precautions:

• Not approved for use in patients younger than 18 years; safety and effectiveness in children are not established.
• Use caution in people with existing corneal disease, prior corneal surgery, or conditions that affect the corneal endothelium, because corneal edema has been reported.
• Pregnancy: data in pregnant women are limited; because systemic absorption from the eye is low, risk is thought to be low but the drug should be used only if the potential benefit justifies any potential risk.
• Breastfeeding: it is not known if netarsudil passes into human milk after eye use; discuss risks and benefits with a healthcare provider.
• Contact lenses: the preservative benzalkonium chloride can be absorbed by soft lenses; remove lenses before using the drops and wait at least 15 minutes before reinserting.

Safety compared with other glaucoma drugs: Rhopressa’s side effects are largely limited to the eye, with minimal systemic effects, but eye redness and local irritation occur more frequently than with many other glaucoma drops; systemic side effects such as effects on heart rate or blood pressure are uncommon compared with beta‑blocker eye drops.

Reporting side effects and safety updates: Patients should report troublesome or serious side effects to their eye doctor, and side effects can also be reported directly to the FDA through the MedWatch program (online or by calling 1‑800‑FDA‑1088) or to the manufacturer via the phone number on the package.

Drug and product interactions:

• Because netarsudil is applied to the eye and systemic absorption is very low, significant interactions with oral prescription drugs, OTC medicines, or supplements are unlikely.
• When used with other prescription eye drops to lower eye pressure, space each medicine at least 5 minutes apart so one drop does not wash out the other.
• Using multiple preserved eye drops (especially those containing benzalkonium chloride) may increase eye surface irritation; your doctor may adjust your regimen if irritation occurs.

Food, alcohol, and procedure interactions:

• No specific food or alcohol interactions are known with Rhopressa.
• Tell your eye doctor you are using Rhopressa before eye surgery or laser procedures, as dosing might need to be adjusted around the time of the procedure.

Precautions and situations where use may be unsafe or need caution:

• History of corneal disease, corneal edema, or prior corneal surgery, because further corneal changes may occur.
• Active eye infection, significant eye inflammation, or recent eye trauma, where your doctor may temporarily stop or modify therapy.
• Pregnancy or breastfeeding, where limited human data mean the decision to use the medication should weigh benefits and potential risks.

Monitoring needs: Regular follow-up with an eye care professional is needed to monitor intraocular pressure, check vision and the optic nerve, and examine the cornea and eye surface for changes; additional systemic tests (such as blood tests or ECGs) are generally not required solely because of Rhopressa use.

Q: What is Rhopressa used for?
A: Rhopressa is an eye drop used once daily to lower high pressure inside the eye in adults with open-angle glaucoma or ocular hypertension.

Q: How long does it take for Rhopressa to start working?
A: The drops begin lowering eye pressure within hours, and your doctor typically evaluates the full effect over several days to a few weeks of regular nightly use.

Q: Can I use Rhopressa with my contact lenses?
A: Yes, but you should remove soft contact lenses before using the drops, wait at least 15 minutes after instilling Rhopressa, and then reinsert your lenses.

Q: What if I accidentally miss my evening dose?
A: If you miss a dose, simply skip it and use the next dose at your usual time the following evening; do not use extra drops to make up for the missed dose.

Q: Will Rhopressa change my eye color or eyelashes?
A: Unlike some prostaglandin glaucoma drops, Rhopressa is not known for causing permanent eye color change or marked eyelash growth, though it can cause eye redness and other local eye effects.

Storage: Before opening, keep Rhopressa in the refrigerator at 36°F to 46°F (2°C to 8°C); after opening, you may store it in the refrigerator or at room temperature 36°F to 77°F (2°C to 25°C) for up to 6 weeks, or keep it refrigerated and use it until the expiration date on the bottle.

Handling: Keep the bottle tightly closed when not in use, do not freeze, protect it from contamination by not touching the dropper tip, and store out of reach of children.

Disposal: Discard the bottle after 6 weeks at room temperature use or when it reaches the expiration date, whichever comes first, and throw it away in household trash unless your community offers a medicine take-back program; do not pour unused drops down the sink or toilet unless instructed.